Display options
Cite
Khandwala NS, Hyde RA, Besirli CG. Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient. Case Rep Ophthalmol. 2021;12(1):259-263doi: 10.1159/000512286.
Khandwala, N. S., Hyde, R. A., & Besirli, C. G. (2021). Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient. Case reports in ophthalmology, 12(1), 259-263. https://doi.org/10.1159/000512286
Khandwala, Nikhila S, et al. "Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient." Case reports in ophthalmology vol. 12,1 (2021): 259-263. doi: https://doi.org/10.1159/000512286
Khandwala NS, Hyde RA, Besirli CG. Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient. Case Rep Ophthalmol. 2021 Apr 16;12(1):259-263. doi: 10.1159/000512286. eCollection 2021. PMID: 34054467; PMCID: PMC8138240.
Copy Download .nbib Format: NLM
Share it on

Case Rep Ophthalmol. 2021 Apr 16;12(1):259-263. doi: 10.1159/000512286. eCollection 2021.

Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient.

Case reports in ophthalmology

Nikhila S Khandwala, Robert A Hyde, Cagri G Besirli

Affiliations

  1. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
  2. Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago, Illinois, USA.

PMID: 34054467 PMCID: PMC8138240 DOI: 10.1159/000512286

Abstract

We present a pediatric case to highlight the clinical appearance and management of choroidal neovascularization in the setting of active toxoplasma retinochoroiditis (TRC). A 17-year-old female presented with 2 days of blurry vision in her left eye. Retinal examination demonstrated a pigmented chorioretinal lesion with associated subretinal fluid, vessel sheathing, and adjacent intraretinal hemorrhage. She was diagnosed with active choroidal neovascularization and successful treatment with bevacizumab revealed an underlying active toxoplasmosis lesion. Choroidal neovascularization may rarely present during an acute case of TRC. Dual therapy with anti-vascular endothelial growth factor antibody and anti-parasitic agents leads to improved visual outcomes.

Copyright © 2021 by S. Karger AG, Basel.

Keywords: Choroidal neovascularization; Retinal lesion; Subretinal fluid; Toxoplasma retinochoroiditis

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Korean J Parasitol. 2013 Aug;51(4):393-9 - PubMed
  2. Indian J Ophthalmol. 2011 Jan-Feb;59(1):62-4 - PubMed
  3. Arch Ophthalmol. 1969 Apr;81(4):481-93 - PubMed
  4. Jpn J Ophthalmol. 2004 Jul-Aug;48(4):386-91 - PubMed
  5. Br J Ophthalmol. 1982 Aug;66(8):524-9 - PubMed
  6. Br J Ophthalmol. 1977 Nov;61(11):693-8 - PubMed
  7. J Fr Ophtalmol. 1984;7(3):211-8 - PubMed
  8. Ophthalmology. 1982 Nov;89(11):1289-90 - PubMed
  9. J Ophthalmic Inflamm Infect. 2015 Jul 12;5:22 - PubMed
  10. Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1157-61 - PubMed
  11. Curr Opin Ophthalmol. 2002 Dec;13(6):387-92 - PubMed
  12. Cureus. 2019 Feb 4;11(2):e4001 - PubMed

Publication Types